Oppenheimer Asset Management Inc. Amicus Therapeutics, Inc. Transaction History

Oppenheimer Asset Management Inc.

$7.94 Billion
Q4 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 23,260 shares of FOLD stock, worth $208,874. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,260

Previous 33,000 29.52%

Holding current value

$208,874

Previous $352,000 37.78%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$9.36 - $12.01 $91,166 - $116,977	-9,740 Reduced 29.52%	23,260 $219,000
Q3 2024 Nov 05, 2024	SELL	$9.55 - $12.09 $175,261 - $221,875	-18,352 Reduced 35.74%	33,000 $352,000
Q2 2024 Aug 08, 2024	BUY	$9.04 - $11.75 $99 - $129	11 Added 0.02%	51,352 $509,000
Q1 2024 May 06, 2024	BUY	$11.43 - $14.24 $1,805 - $2,249	158 Added 0.31%	51,341 $604,000
Q4 2023 Feb 13, 2024	SELL	$9.97 - $14.52 $78,394 - $114,170	-7,863 Reduced 13.32%	51,183 $726,000
Q3 2023 Nov 07, 2023	SELL	$11.78 - $13.86 $2,356 - $2,772	-200 Reduced 0.34%	59,046 $717,000
Q2 2023 Aug 02, 2023	SELL	$10.72 - $13.3 $36,104 - $44,794	-3,368 Reduced 5.38%	59,246 $744,000
Q1 2023 May 10, 2023	SELL	$10.91 - $13.54 $48,702 - $60,442	-4,464 Reduced 6.65%	62,614 $694,000
Q4 2022 Feb 06, 2023	BUY	$9.89 - $12.7 $120,717 - $155,016	12,206 Added 22.24%	67,078 $819,000
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $21,122 - $27,425	-2,151 Reduced 3.77%	54,872 $573,000
Q2 2022 Aug 08, 2022	SELL	$6.23 - $11.12 $19,381 - $34,594	-3,111 Reduced 5.17%	57,023 $612,000
Q1 2022 May 12, 2022	BUY	$7.89 - $12.48 $41,540 - $65,707	5,265 Added 9.6%	60,134 $569,000
Q4 2021 Feb 02, 2022	BUY	$9.82 - $12.44 $116,042 - $147,003	11,817 Added 27.45%	54,869 $634,000
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $23,187 - $31,411	-2,653 Reduced 5.8%	43,052 $411,000
Q2 2021 Aug 03, 2021	SELL	$8.71 - $10.72 $6,941 - $8,543	-797 Reduced 1.71%	45,705 $441,000
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $427,818 - $1.11 Million	46,502 New	46,502 $459,000

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

311M

Call Options Held

467K

Put Options Held

515K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.52B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Amicus Therapeutics, Inc. Transaction History